Molnar Miklos Z, Ichii Hirohito, Lineen James, Foster Clarence E, Mathe Zoltan, Schiff Jeffrey, Kim S Joseph, Pahl Madeleine V, Amin Alpesh N, Kalantar-Zadeh Kamyar, Kovesdy Csaba P
Division of Nephrology and Hypertension, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine Medical Center, Orange, California; Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, UC Irvine School of Medicine, Irvine, California.
Semin Dial. 2013 Nov-Dec;26(6):667-74. doi: 10.1111/sdi.12129. Epub 2013 Sep 9.
In the last decade, the number of patients starting dialysis after a failed kidney transplant has increased substantially. These patients appear to be different from their transplant-naïve counterparts, and so may be the timing of dialysis therapy initiation. An increasing number of studies suggest that in transplant-naïve patients, later dialysis initiation is associated with better outcomes. Very few data are available on timing of dialysis reinitiation in failed transplant recipients, and they suggest that an earlier return to dialysis therapy tended to be associated with worse survival, especially among healthier and younger patients and women. Failed transplant patients may also have unique issues such as continuation of immunosuppression versus withdrawal or the need for remnant allograft nephrectomy with regard to dialysis reinitiation. These patients may have a different predialysis preparation work-up, worse blood pressure control, higher or lower serum phosphorus levels, lower serum bicarbonate concentration, and worse anemia management. The choice of dialysis modality may also represent an important question for these patients, even though there appears to be no difference in mortality between patients starting peritoneal versus hemodialysis. Finally, failed transplant patients returning to dialysis appear to have a higher mortality rate compared with transplant-naïve incident dialysis patients, especially in the first several months of dialysis therapy. In this review, we will summarize the available data related to the timing of dialysis initiation and outcomes in failed kidney transplant patients after returning to dialysis.
在过去十年中,肾移植失败后开始透析的患者数量大幅增加。这些患者似乎与未曾接受过移植的患者不同,透析治疗开始的时机可能也有所不同。越来越多的研究表明,在未曾接受过移植的患者中,较晚开始透析与更好的预后相关。关于移植失败受者重新开始透析的时机,可用数据非常少,这些数据表明较早恢复透析治疗往往与较差的生存率相关,尤其是在健康状况较好、较年轻的患者以及女性中。移植失败的患者在重新开始透析方面可能还存在一些独特的问题,例如免疫抑制是继续还是停用,或者是否需要进行残余同种异体肾切除术。这些患者可能有不同的透析前准备检查、更差的血压控制、更高或更低的血清磷水平、更低的血清碳酸氢盐浓度以及更差的贫血管理。透析方式的选择对这些患者来说可能也是一个重要问题,尽管开始腹膜透析与血液透析的患者在死亡率上似乎没有差异。最后,与未曾接受过移植的初发透析患者相比,重新开始透析的移植失败患者似乎有更高的死亡率,尤其是在透析治疗的最初几个月。在这篇综述中,我们将总结与肾移植失败患者重新开始透析后透析开始时机及预后相关的现有数据。